ArticleCancer immunology, immunotherapy : CII2018

Blood cell count indexes as predictors of outcomes in advanced non-small-cell lung cancer patients treated with Nivolumab.

Carlo Putzu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.